Labcorp Holdings Inc. provides comprehensive laboratory services that help doctors, hospitals, pharmaceutical companies, researchers and patients make clear and confident decisions. The Company provides insights and accelerates to improve health and improve lives through its unparalleled diagnostics and drug development capabilities. The Company operates through two segments: Diagnostics Laboratories (Dx) and Biopharma Laboratory Services (BLS). The Diagnostics Laboratories segment includes routine testing and specialty/esoteric testing. Dx operates through a network of patient service centers, branches, rapid response laboratories, primary laboratories, and specialty laboratories. The Biopharma Laboratory Services segment consists of early development research laboratories and central laboratory services. The Company is focused on four primary specialty testing areas, such as oncology, women's health, autoimmune disease, and neurology.
Alto Crescimento de Lucro
O lucro líquido da empresa lidera o setor, com o lucro anual mais recente totalizando US$ 13.95B.
Alto Dividendo
A empresa é uma grande pagadora de dividendos, com índice de distribuição mais recente de 32.56%.
Subavaliada
O PE mais recente da empresa é 23.89, em uma faixa percentil baixa de 3 anos.
Compra Institucional
As participações institucionais mais recentes são de 88.74M ações, um aumento de 5.91% em relação ao trimestre anterior.
Mantido por Wallace Weitz
O Super Investidor Wallace Weitz possui 102.34K ações desta empresa.